The high cost of chemotherapy drugs has been in the news a lot lately, and blood cancer is at the forefront of it all. I wrote a blog post about it on our other website, HelpWithCancer.org. I only post there once a week or so these days. Reflecting back a few days, I should have
Here is a link to an abstract with an update about advances in stem cell mobilization: Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.Interpreting this is beyond my pay grade! Best I can tell, AMD3100 is a new stem cell mobilizer, with possible benefits as a
Reflections From A Caregiver: "In this cancer community of survivors, how do we promote the power of positive thinking and not leave behind those who’s treatments are failing to impact the disease?"
I have been e-mailing back and forth with a caregiver named Kate. She originally contacted me about an article I wrote last week, An Ambiguous Multiple Myeloma Maintenance Therapy Study Is Still Worth A Look. As I often do, I was commenting on one of the numerous research studies I often read. Here is the
Most oncologists know not to administer melphalan chemotherapy for myeloma patients that need stem cells harvested for possible transplant. But far fewer are aware of the negative effects radiation therapy can have on a patient's ability to mobilize stem cells into the blood for harvest. I had a very difficult time producing enough stem cells